ELEVAI LABS INC (ELAB)

Company Profile

Elevai Labs, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. The company is headquartered in Newport Beach, California and currently employs 18 full-time employees. The company went IPO on 2023-11-21. The firm conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. The company produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical cord-derived mesenchymal stem cells (hUMSC) for its specialty physician-dispensed skincare product lines. The company has integrated the use of stem cell exosomes into its initial product line: Elevai Post Treatment E-Series. The E-Series comprises two post-skincare procedure care products that target the face and neck, and upper chest regions. Its products include Empower and Enfinity serums. Empower is its after-treatment topical product that supports the appearance of healthy skin and promotes an even toned complexion.

Company Info

ELEVAI LABS INC

120 Newport Center Drive, Ste 250

Newport Beach CALIFORNIA

P: 18667944940

Employees: 18

Website: https://elevaiskincare.com/